Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q4 2021 Results Earnings Conference Call February 24, 2022 8:00 AM ET
Company Participants
Holly Manning - Senior Director of Investor Relations
Jackie Fouse - Chief Executive Officer
Sarah Gheuens - Chief Medical Officer
Richa Poddar - Chief Commercial Officer
Jonathan Biller - Chief Financial Officer and Head of Corporate Affairs
Conference Call Participants
Marc Frahm - Cowen and Company
Anupam Rama - J.P. Morgan
Kennen McKay - RBC Capital Markets
Alethia Young - Cantor Fitzgerald
Greg Harrison - Bank of America
Mark Breidenbach - Oppenheimer
Salveen Richter - Goldman Sachs
Madison Suhr - Raymond James
John Newman - Canaccord Genuity
Operator
Good morning and welcome to Agios' Fourth Quarter 2021 Conference Call. At this time, all participants are in listen-only mode. There will be a question-and-answer session at the end. Please be advised that this call is being recorded at Agios' request.
I would now like to turn the call over to Holly Manning, Senior Director of Investor Relations.
Holly Manning
Thank you, operator. Good morning, everyone, and welcome to Agios' Fourth Quarter 2021 Conference Call. You can access slides for today's call by going to the Investors section of our website, agios.com.
With me on the call today with prepared remarks are Dr. Jackie Fouse, our Chief Executive Officer; Dr. Sarah Gheuens, our Chief Medical Officer; Richa Poddar, our Chief Commercial Officer; Jonathan Biller, our Chief Financial Officer and Head of Corporate Affairs; and Dr. Bruce Car, our Chief Scientific Officer, who will join for Q&A.
Before we get started, I would like to remind everyone that some of the statements we make on this call will include forward-looking statements. Actual events and results could differ materially from those expressed or implied by any forward-looking statements as a result of various risks, uncertainties and other factors including
- Read more current AGIO analysis and news
- View all earnings call transcripts